HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glikopin

a Russian drug; chemically synthesized; from the peptidoglycan

Also Known As:

likopid

Networked: 13 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Amino Sugars: 110
  - Muramic Acids: 28
    - Acetylmuramyl-Alanyl-Isoglutamine: 467
      - glikopin: 13
- Sugar Acids: 4
  - Muramic Acids: 28
    - Acetylmuramyl-Alanyl-Isoglutamine: 467
      - glikopin: 13
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Glycopeptides: 1928
    - Acetylmuramyl-Alanyl-Isoglutamine: 467
      - glikopin: 13

Experts

1.	Pinegin, B V: 3 articles (01/2002 - 01/2000)
2.	Rabinovich, O F: 2 articles (01/2013 - 01/2000)
3.	Simonova, A V: 2 articles (01/2002 - 01/2001)
4.	Ushkalova, E A: 1 article (12/2019)
5.	Zatolochina, K E: 1 article (12/2019)
6.	Zyryanov, S K: 1 article (12/2019)
7.	Fazylov, V Ch: 1 article (01/2017)
8.	Guryanova, S V: 1 article (01/2017)
9.	Manapova, E R: 1 article (01/2017)
10.	Chop'iak, V V: 1 article (03/2013)

Related Diseases

1.	Chronic Bronchitis 01/01/1998 - "[The clinico-immunological efficacy of the likopid treatment of chronic bronchitis patients]." 01/01/1998 - "Elucidation of likopid effect on clinical and immunological pictures in patients with chronic bronchitis (CB). "
2.	Dysbiosis 01/01/2013 - "The aim of the study was to assess likopid effectiveness in complex treatment of oral dysbiosis. " 01/01/2013 - "[Likopid in complex treatment of oral dysbiosis]."
3.	Psoriasis (Pustulosis Palmaris et Plantaris) 12/15/2019 - "It is emphasized that in diseases associated with human papillomavirus and plaque psoriasis, according to current criteria of evidence - based medicine, Likopid should be classified as drug with level A efficacy (high efficiency in 80-100% of patients). " 12/15/2019 - "The results of Likopid studies when used as a prophylactic and therapeutic agent for infections of various localization in adults and children, for oncological diseases and complications of chemotherapy and radiation therapy, psoriasis, atopic and other diseases are presented. "
4.	Infections 12/15/2019 - "The results of Likopid studies when used as a prophylactic and therapeutic agent for infections of various localization in adults and children, for oncological diseases and complications of chemotherapy and radiation therapy, psoriasis, atopic and other diseases are presented. "
5.	Chronic Hepatitis C 01/01/2017 - "Thus, for the first time experimental evidence is presented for the effectiveness of medicinal likopid correction of neutropenia and thrombocytopenia in patients with chronic hepatitis C (genotype 1), which indicates the feasibility of introducing likopid into the antiviral therapy." 01/01/2017 - "With the development of moderate "early" (less than 12 weeks of antiviral therapy) and for the prevention of "late" (more than 12 weeks of treatment) neutropenia, appointment of immune medicine likopid (glucosaminylmuramyldipeptide) at a dosage of 1 mg, 2 times a day for 20 days, in patients with chronic hepatitis C (genotype 1b ) with <F3 fibrosis significantly stimulates leucopoiesis and increases the number of neutrophils and platelets, which makes it possible to avoid reduction of the dose of interferon and to increase the efficiency of the antiviral therapy. "

Related Drugs and Biologics

1.	Immunologic Factors (Immunomodulators)
2.	Cytokines
3.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
4.	Lipids
5.	Interferons
6.	Free Radicals
7.	Antiviral Agents (Antivirals)
8.	glucosaminylmuramyl- 2- alanine- D- isoglutamine

Related Therapies and Procedures

1.	Radiotherapy
2.	Drug Therapy (Chemotherapy)
3.	Therapeutics
4.	Conservative Treatment